Cell Proliferation and Cytotoxicity Assays

dc.contributor.author Adan, Aysun
dc.contributor.author Kiraz, Yagmur
dc.contributor.author Baran, Yusuf
dc.contributor.department AGÜ, Yaşam ve Doğa Bilimleri Fakültesi, Moleküler Biyoloji ve Genetik Bölümü en_US
dc.contributor.institutionauthor Adan, Aysun
dc.contributor.institutionauthor Kiraz, Yagmur
dc.contributor.institutionauthor Baran, Yusuf
dc.date.accessioned 2021-10-09T09:49:22Z
dc.date.available 2021-10-09T09:49:22Z
dc.date.issued 2016 en_US
dc.description.abstract Cell viability is defined as the number of healthy cells in a sample and proliferation of cells is a vital indicator for understanding the mechanisms in action of certain genes, proteins and pathways involved cell survival or death after exposing to toxic agents. Generally, methods used to determine viability are also common for the detection of cell proliferation. Cell cytotoxicity and proliferation assays are generally used for drug screening to detect whether the test molecules have effects on cell proliferation or display direct cytotoxic effects. Regardless of the type of cell-based assay being used, it is important to know how many viable cells are remaining at the end of the experiment. There are a variety of assay methods based on various cell functions such as enzyme activity, cell membrane permeability, cell adherence, ATP production, co-enzyme production, and nucleotide uptake activity. These methods could be basically classified into different categories: (I) dye exclusion methods such as trypan blue dye exclusion assay, (II) methods based on metabolic activity, (III) ATP assay, (IV) sulforhodamine B assay, (V) protease viability marker assay, (VI) clonogenic cell survival assay, (VII) DNA synthesis cell proliferation assays and (V) raman micro-spectroscopy. In order to choose the optimal viability assay, the cell type, applied culture conditions, and the specific questions being asked should be considered in detail. This particular review aims to provide an overview of common cell proliferation and cytotoxicity assays together with their own advantages and disadvantages, their methodologies, comparisons and intended purposes. en_US
dc.identifier.issn 1389-2010
dc.identifier.issn 1873-4316
dc.identifier.other PubMed ID27604355
dc.identifier.uri https //doi.org/10.2174/1389201017666160808160513
dc.identifier.uri https://hdl.handle.net/20.500.12573/980
dc.identifier.volume Volume 17 Issue 14 Page 1213-1221 en_US
dc.language.iso eng en_US
dc.publisher BENTHAM SCIENCE PUBL LTDEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES en_US
dc.relation.isversionof 10.2174/1389201017666160808160513 en_US
dc.relation.journal CURRENT PHARMACEUTICAL BIOTECHNOLOGY en_US
dc.relation.publicationcategory Diğer en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject viability en_US
dc.subject tetrazolium en_US
dc.subject raman-microspectroscopy en_US
dc.subject Ki-67 en_US
dc.subject cytotoxicity en_US
dc.subject Alamar blue en_US
dc.title Cell Proliferation and Cytotoxicity Assays en_US
dc.type review en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: